Celestra Health Systems is an award-winning company that is advancing the treatment of Multiple Sclerosis (MS) through the combination of cutting-edge wearable technology, smart phone application software and cloud-based Artificial Intelligence (AI). By unobtrusively collecting data from sensors embedded in a “smart insole” fitted into the patient’s everyday footwear, Celestra Health’s AI engine learns each patient’s unique walking signature and monitors for changes, acting as an early warning system for changes in disease condition. Celestra Health’s advanced AI algorithms can detect walking subtleties that would not otherwise be observable; for the first time ever, clinicians can objectively measure the severity of MS-specific gait patterns to better inform their treatment recommendations. Celestra Health is a privately held corporation headquartered in Ottawa, back by Wesley Clover International, a global investment company with over $1B in assets.